These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 10703891

  • 1. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.
    Fabris B, Candido R, Armini L, Fischetti F, Calci M, Bardelli M, Fazio M, Campanacci L, Carretta R.
    J Hypertens; 1999 Dec; 17(12 Pt 2):1925-31. PubMed ID: 10703891
    [Abstract] [Full Text] [Related]

  • 2. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB, Jovović Dj, Varagić J, Dimitrijević J, Dragojlović Z, Djukanović L.
    Srp Arh Celok Lek; 2002 Dec; 130(3-4):73-80. PubMed ID: 12154518
    [Abstract] [Full Text] [Related]

  • 3. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
    Cooper ME, Allen TJ, O'Brien RC, Papazoglou D, Clarke BE, Jerums G, Doyle AE.
    Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881
    [Abstract] [Full Text] [Related]

  • 4. Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance.
    Yang LE, Leong PK, McDonough AA.
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1197-208. PubMed ID: 17652375
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G.
    Exp Nephrol; 1994 Oct; 2(4):220-8. PubMed ID: 8069658
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.
    Cooper ME, Rumble JR, Allen TJ, O'Brien RC, Jerums G, Doyle AE.
    Kidney Int; 1992 Apr; 41(4):898-903. PubMed ID: 1513111
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model.
    Raij L, Chiou XC, Owens R, Wrigley B.
    Am J Med; 1985 Sep 27; 79(3C):37-41. PubMed ID: 2996345
    [Abstract] [Full Text] [Related]

  • 9. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D, Jovovic D, Mihailovic-Stanojevic N, Miloradovic Z, Naumovic R, Dimitrijevic J, Maksic N, Djukanovic L.
    Biomed Pharmacother; 2009 Sep 27; 63(8):571-6. PubMed ID: 19013753
    [Abstract] [Full Text] [Related]

  • 10. Effects of antihypertensive drugs on antioxidant enzyme activities and renal function in stroke-prone spontaneously hypertensive rats.
    Shou I, Wang LN, Suzuki S, Fukui M, Tomino Y.
    Am J Med Sci; 1997 Dec 27; 314(6):377-84. PubMed ID: 9413342
    [Abstract] [Full Text] [Related]

  • 11. Perindopril ameliorates glomerular and renal tubulointerstitial injury in the SHR/N-corpulent rat.
    Velasquez MT, Striffler JS, Abraham AA, Michaelis OE, Scalbert E, Thibault N.
    Hypertension; 1997 Nov 27; 30(5):1232-7. PubMed ID: 9369281
    [Abstract] [Full Text] [Related]

  • 12. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct 27; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 13. Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat.
    Ding SS, Qiu C, Hess P, Xi JF, Zheng N, Clozel M.
    J Cardiovasc Pharmacol; 2003 Jul 27; 42(1):48-54. PubMed ID: 12827026
    [Abstract] [Full Text] [Related]

  • 14. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y, Bélanger A, Godin C, Hallé JP, Ross S, Wright N, Marion J.
    Kidney Int; 2000 Aug 27; 58(2):762-9. PubMed ID: 10916100
    [Abstract] [Full Text] [Related]

  • 15. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun 28; 349(9069):1857-63. PubMed ID: 9217756
    [Abstract] [Full Text] [Related]

  • 16. Salt blocks the renal benefits of ramipril in diabetic hypertensive rats.
    Fabris B, Jackson B, Johnston CI.
    Hypertension; 1991 Apr 28; 17(4):497-503. PubMed ID: 1826492
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S, Rennke HG, Brenner BM.
    J Clin Invest; 1986 Jun 28; 77(6):1993-2000. PubMed ID: 3011863
    [Abstract] [Full Text] [Related]

  • 18. Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats.
    Yamamoto M, Fukui M, Shou I, Wang LN, Sekizuka K, Suzuki S, Shirato I, Tomino Y.
    J Clin Lab Anal; 1997 Jun 28; 11(1):53-62. PubMed ID: 9021525
    [Abstract] [Full Text] [Related]

  • 19. Short and long term effects of antihypertensive therapy in the diabetic rat.
    Anderson S, Rennke HG, Garcia DL, Brenner BM.
    Kidney Int; 1989 Oct 28; 36(4):526-36. PubMed ID: 2681929
    [Abstract] [Full Text] [Related]

  • 20. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 28; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.